Metabolic Cross Talk in the Tumor Microenvironment
Chinmay Das1, Somya Ranjan Dash2, Biswajit Das3
1School of Biotechnology, Kalinga Institute of Industrial Technology Deemed to be University, Bhubaneswar, Odisha, India.
Cancer Treatment and Research
|May 17, 2026
Summary
Cancer cells and tumor microenvironment cells engage in metabolic crosstalk, reprogramming metabolism to fuel cancer progression and drug resistance. Understanding these interactions is key to developing new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Metabolism
Background:
- The tumor microenvironment (TME) comprises malignant, immune, stromal, endothelial cells, and the extracellular matrix.
- Metabolic interactions within the TME significantly influence cancer progression, immune evasion, metastasis, and therapeutic resistance.
Purpose of the Study:
- To provide a comprehensive overview of metabolic interactions between malignant and TME cells.
- To highlight the role of key metabolites in TME communication.
- To explore molecular mechanisms driving metabolic reprogramming in cancer.
Main Methods:
- Literature review and synthesis of current research on TME metabolic crosstalk.
- Analysis of autocrine, paracrine, juxtacrine, and endocrine-like communication pathways.
- Examination of signaling pathways triggered by metabolite exchange.
Main Results:
- Dynamic metabolic crosstalk within the TME supports cancer progression under stress conditions (hypoxia, acidosis).
- Metabolic reprogramming of tumor-resident cells is crucial for cancer survival and growth.
- Metabolite exchange between malignant and stromal cells promotes drug resistance.
Conclusions:
- Metabolic interactions within the TME are critical drivers of cancer progression and drug resistance.
- Targeting metabolic vulnerabilities in cancer cells presents a promising therapeutic strategy.
- Understanding TME metabolic reprogramming is essential for novel cancer treatment development.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...